Interesting reversal in private / public market financing with recent Lux Capital ETF launch with First Trust. Private market insights -> Public market insights. Not the first time we're seeing a VC doing this and likely more to co… https://t.co/KsluNvAF2W

Great start to the ABHI UK delegation in Fort Worth today! I'm in Texas promoting Labgnostic for lab-to-lab interoperability in the US. On the panel Moderating: @DrTonyYoung at NHS England @jd1aggie President of TEXAS HEALTH HARRIS METHODIST HOSPITAL FO… https://t.co/rXMphjQFeI

Labgnostic was recently featured in Medical Lab Management "In the United States, heath systems often operate or interact with various laboratory entities and facilities. Some of these lab facilities may be owned by the health sys… https://t.co/xxeeE5kMwU

Simple, effective communication from @rjs

https://t.co/sCBozovySH

MedTech Money: Analysis of Series B rounds provides an interesting view of the US venture market. Series B companies typically have established product market fit and are prepared for scaling on their way towards an exit event. Av… https://t.co/zQpF19DSLf

A nicely written and well-referenced article from Micky Tripathi on changes coming down the pike as a result of the 21st Century Cures Act. Big changes in #healthcare #interoperability set in motion. Keeping my eye on CommonWell Health Alliance.

Attention early-stage MedTech inventors and innovators: The The National Institutes of Health and FDA will be presenting a webinar series starting March 16 on the use of regulatory science tools to help accelerate medical device innovation. FDA is helpin… https://t.co/WryD5ExIgu

Some of the best detail you’ll find in 3D neurovascular apps

MedTech Money: Interesting dynamics as large funds move up the pipeline to earlier stage deals. A lot of activity from Tiger Global Management in early stage deals recently. Not uncommon to see them entering into Series A 25M+ deal… https://t.co/YQaccA66Em

MedTech Money: SEC considering changes aimed at private funds and companies to increase transparency. Comment period ends mid-April. #startups #raisingcapital

Big biotech is cash rich - $1.7T in the coffers. While they had $1.2T ready to deploy in 2021, M&A deals were down 40% relative to 2019 levels due to high premiums. Licensing deals have been more common in pandemic times. Lookin… https://t.co/JwucrnQNUt

MedTech Money: Companion Spine raises $55M Series A. Congrats Erick CLOIX and team! The company is commercializing minimally invasive diagnostic and therapeutic solutions for treating degenerative disc disease (DDD) and lumbar spi… https://t.co/EhAjbTziym

This made me laugh

MedTech Money: VC and PE funding remains strong despite recent volatility in public markets. #medtechmoney #medtech #startups #raisingcapital https://t.co/gK6zb43Odg

MedTech Money: With 700+ unicorns in the pipe (across all sectors) all eyes are on public market liquidity. #medtechmoney #medtech #startups #raisingcapital

To my #Angel and #VC colleagues in the #drugdiscovery space: I recently started advising a startup utilizing phage-tech that has potential to take the target ID process from years to weeks. Large contract/strategic partnership with well-known pharmaceuti… https://t.co/0Joy9jHL7q

Gaurav Sharma, MD FCAP has been putting out some great content on #SARSCOV2 and #COVID recently. As a trained physician-pathologist and laboratory medical director at Henry Ford Health System, I consider him a reliable source. This piece is an update on… https://t.co/zQpMTmyIQ2

A Tale of Two Top-Downs: A Two-Part Series A provocative reading from Joseph Norman - I highly recommend. Got me thinking about applicability of complex systems engineering in the med device space. #medtechmoney #medtech #startups #raisingcapital

"Don't just read it; fight it!" I've recently been digging back into probability and statistics and found this great Quora post from Joe Blitzstein. I think it applies broadly and is a great reminder to be actively engaged when di… https://t.co/vT0E8Q4zDN